By Yadarisa Shabong Jan 20 (Reuters) - Britain's GSK and Japan's Shionogi said on Tuesday that Pfizer will exit their HIV ...

Pfizer will relinquish its stake in ViiV Healthcare in a deal valued at just over $2.1 billion that ramps up Shionogi's ...

The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...

Jan 20 (Reuters) - Japan's Shionogi & Co said on Tuesday it would pay $2.13 billion for new shares in ViiV Healthcare, its ...

Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.

Pfizer exits ViiV Healthcare with a $1.89bn payout, while GSK retains its majority stake amid the shareholder shake-up.

Pfizer in ​December had warned that the next few years would be bumpy, ‌beginning with 2026, ‍due to lower sales of its COVID ...

As a result of the acquisition, Pfizer will no longer hold shares of ViiV Healthcare Limited and Shionogi will see its holdings increase to 21.7%. 1 The majority shareholder of ViiV Healthcare Limited ...

GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding: London, UK Wednesday, January 21, 2026, 09:00 Hrs [IST] GSK plc (GSK), and Shionogi & Co., Ltd (Shionogi ...

In recent decades, merger and acquisition activity has sent long-standing Michigan businesses' leadership out-of-state and even the country.

By Puyaan Singh and Sneha S K Jan 22 (Reuters) - The Trump administration has rolled back decades-old guidance recommending routine childhood vaccination against influenza and three other infectious ...

The Trump administration has rolled back decades-old guidance recommending routine childhood vaccination against influenza and three other infectious diseases, saying their use should instead be ...